PentaBase A/S
Pentabase A/S – Commerical Lead UK and Ireland
Web: www.pentabase.com
Product area: Genetics IVD – oncology and haematology applications
Customer groups: Genetic testing laboratory network
What is my role?
Leading UK & Ireland commercial development for PentaBase A/S, a Danish molecular diagnostics company specialising in advanced PCR technologies for oncology and haematology.
My role combines hands-on market development with wider IVD commercial strategy and advisory support, including:
- UK & Ireland market strategy and opportunity development
- Building engagement across NHS Genomic Laboratory Hubs, private laboratories and research institutions
- Developing early-adopter, evaluation and reference sites
- Supporting opportunities across methylation, MSI, MRD and bespoke molecular assays
- Key account development and pharmaceutical collaborations
- Wider commercial strategy, market positioning and marketing advisory
Hycor BV
Hycor Ltd – Adviser and early commerical engagment
Web: hycorbiomedical.com
Product area: IVD
Customer groups: Laboratories and clinicians
What is my role?
Working directly with the European Commercial Director, this longer-term consultancy engagement supports the introduction of the NOVEOS-Flex immunology diagnostic system within the UK market.
The role includes laboratory engagement, market development and strategic advisory across commercial strategy, scientific affairs, site evaluations and direct customer engagement.
Diagenics Ltd
Diagenics – Adviser for strategy, aquistion and direct commerical engagement
Web: diagenics.co.uk
Product area: IVD including POCT, Pharmaceuticals
Customer groups: Laboratories and clinicians
Diagenics is UK product distributor which focuses on distribution of diagnostics and pharmaceutical within Immunology and dematology
What was my role?
Supported the leadership team in reviewing and refining the go-to-market strategy for diagnostic and immunotherapy products within the UK healthcare market, combining strategic advisory support with commercial engagement and portfolio evaluation.